Fructose intake and risk of gout and hyperuricemia: A systematic review and meta-analysis of prospective cohort studies

BMJ Open

Volumn 6, Issue 10, 2016, Pages

  Jamnik, Joseph ^a   Rehman, Sara ^a,b   Blanco Mejia, Sonia ^a,b   De Souza, Russell J ^b,c   Khan, Tauseef A ^a,b   Leiter, Lawrence A ^a,b,d   Wolever, Thomas M S ^a,b,d   Kendall, Cyril W C ^a,b,e   Jenkins, David J A ^a,b,d   Sievenpiper, John L ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Fructose; Gout; Hyperuricemia; Systematic review

Indexed keywords

FRUCTOSE;

ARTICLE; COHORT ANALYSIS; FOLLOW UP; GOUT; HUMAN; HYPERURICEMIA; INCIDENCE; PROSPECTIVE STUDY; RISK FACTOR; SYSTEMATIC REVIEW; ADULT; AGED; CARBOHYDRATE DIET; DIET; FEMALE; MALE; META ANALYSIS; MIDDLE AGED;

ADULT; AGED; DIET; DIETARY CARBOHYDRATES; FEMALE; FRUCTOSE; GOUT; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED;

EID: 84990032723     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-013191     Document Type: Article

References (61)

1. Richette P, Bardin T. Gout. Lancet 2010;375:318-28.
2. Schumacher HR Jr. The pathogenesis of gout. Cleve Clin J Med 2008;75(Suppl 5):S2-4.
3. Grassi D, Ferri L, Desideri G, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des 2013;19:2432-8.
4. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63:3136-41.
5. Arromdee E, Michet CJ, Crowson CS, et al. Epidemiology of gout: is the incidence rising J Rheumatol 2002;29:2403-6.
6. Kuo CF, Grainge MJ, Zhang W, et al. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015;11:649-62.
7. Aune D, Norat T, Vatten LJ. Body mass index and the risk of gout: A systematic review and dose-response meta-analysis of prospective studies. Eur J Nutr 2014;53:1591-601.
8. Wang M, Jiang X, Wu W, et al. A meta-analysis of alcohol consumption and the risk of gout. Clin Rheumatol 2013;32:1641-8.
9. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103.
10. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005;52:283-9.
11. Kedar E, Simkin PA. A perspective on diet and gout. Adv Chronic Kidney Dis 2012;19:392-7.
12. Rho YH, Zhu Y, Choi HK. The epidemiology of uric acid and fructose. Semin Nephrol 2011;31:410-19.
13. Hess J, Latulippe ME, Ayoob K, et al. The confusing world of dietary sugars: definitions, intakes, food sources and international dietary recommendations. Food Funct 2012;3:477-86.
14. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages May play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537-43.
15. Raivio KO, Becker A, Meyer LJ, et al. Stimulation of human purine synthesis de novo by fructose infusion. Metab Clin Exp 1975;24:861-9.
16. Stirpe F, Della Corte E, Bonetti E, et al. Fructose-induced hyperuricaemia. Lancet 1970;2:1310-11.
17. Cox CL, Stanhope KL, Schwarz JM, et al. Consumption of fructosebut not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutr Metab (Lond) 2012;9:68.
18. Ha V, Jayalath VH, Cozma AI, et al. Fructose-containing sugars, blood pressure, and cardiometabolic risk: A critical review. Curr Hypertens Rep 2013;15:281-97.
19. Wang DD, Sievenpiper JL, de Souza RJ, et al. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J Nutr 2012;142:916-23.
20. Higgins JPT, Greenn S, Collaboration C. Cochrane handbook for systematic reviews of interventions. Chichester, UK; Hoboken (NJ): Wiley-Blackwell, 2008.
21. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
22. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www. ohri. ca/programs/clinical-epidemiology/ oxford. Asp
23. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383-94.
24. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 2011;64:395-400.
25. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;64:401-6.
26. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol 2011;64:407-15.
27. Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol 2011;64:1277-82.
28. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 6. Rating the quality of evidence-imprecision. J Clin Epidemiol 2011;64:1283-93.
29. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol 2011;64:1294-302.
30. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 8. Rating the quality of evidence-indirectness. J Clin Epidemiol 2011;64:1303-10.
31. Guyatt GH, Oxman AD, Sultan S, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011;64:1311-16.
32. Brunetti M, Shemilt I, Pregno S, et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. J Clin Epidemiol 2013;66:140-50.
33. Guyatt G, Oxman AD, Sultan S, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a singleoutcome and for all outcomes. J Clin Epidemiol 2013;66:151-7.
34. Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 2013;66:158-72.
35. Guyatt GH, Thorlund K, Oxman AD, et al. GRADE guidelines 13 Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol 2013;66:173-83.
36. The Cochrane Collaboration. The generic inverse variance method. http://cfgd. cochrane. org/search/google-appliance/generic%20inverse %20variance%20method (accessed 28 Jan 2016).
37. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
38. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008;336:309-12.
39. Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010;304:2270-8.
40. Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977;20:895-900.
41. Reginato AM, Mount DB, Yang I, et al. The genetics of hyperuricaemia and gout. Nat Rev Rheumatol 2012;8:610-21.
42. Batt C, Phipps-Green AJ, Black MA, et al. Sugar-sweetened beverage consumption: A risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout. Ann Rheum Dis 2014;73:2101-6.
43. Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: A systematic review of the literature. Curr Opin Rheumatol 2011;23:192-202.
44. Singh JA. Racial and gender disparities among patients with gout. Curr Rheumatol Rep 2013;15:307.
45. Winnard D, Wright C, Taylor WJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 2012;51:901-9.
46. Smith E, Hoy D, Cross M, et al. The global burden of gout: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis 2014;73:1470-6.
47. Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women-the Third National Health and Nutrition Examination Survey. Arthritis Res Ther 2008;10:R116.
48. Hak AE, Curhan GC, Grodstein F, et al. Menopause, postmenopausal hormone use and risk of incident gout. Ann Rheum Dis 2010;69:1305-9.
49. Abeles AM. Hyperuricemia, gout, and cardiovascular disease: An update. Curr Rheumatol Rep 2015;17:13.
50. van Durme C, van Echteld IA, Falzon L, et al. Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: A systematic review of the literature. J Rheumatol Suppl 2014;92:9-14.
51. Choi JW, Ford ES, Gao X, et al. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008;59:109-16.
52. Bomback AS, Derebail VK, Shoham DA, et al. Sugar-sweetened soda consumption, hyperuricemia, and kidney disease. Kidney Int 2010;77:609-16.
53. Stanhope KL, Medici V, Bremer AA, et al. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/ lipoprotein risk factors for cardiovascular disease in young adults. Am J Clin Nutr 2015;101:1144-54.
54. Meneses-Leon J, Denova-Gutiérrez E, Castañón-Robles S, et al. Sweetened beverage consumption and the risk of hyperuricemia in Mexican adults: A cross-sectional study. BMC Public Health 2014;14:445.
55. Sun SZ, Flickinger BD, Williamson-Hughes PS, et al. Lack of association between dietary fructose and hyperuricemia risk in adults. Nutr Metab (Lond) 2010;7:16.
56. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 2009;139:1228S-35S.
57. Choi HK, Mount DB, Reginato AM, et al. Pathogenesis of gout. Ann Intern Med 2005;143:499-516.
58. Wu T, Giovannucci E, Pischon T, et al. Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr 2004;80:1043-9.
59. Quiñones Galvan A, Natali A, Baldi S, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995;268(Pt 1):E1-5.
60. US Department of Health and Human Services; US Department of Agriculture. Scientific report of the 2015 Dietary Guidelines Advisory Committee. Washington (DC): US Government Printing Office, 2015.
61. Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012;64:1431-46.